๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liver transplantation for alpha-1-antitrypsin deficiency in children

โœ Scribed by Andreas A. Prachalias; Mohamed Kalife; Ruggiero Francavilla; Paolo Muiesan; Anil Dhawan; Alastair Baker; D. Hadzic; Giorgina Mieli-Vergani; Mohamed Rela; Nigel D. Heaton


Publisher
Springer
Year
2000
Tongue
English
Weight
57 KB
Volume
13
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Neonatal screening for alpha-1-antitryps
โœ J. Kimpen; E. Bosmans; J. Raus ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 307 KB

The results of a neonatal screening programme for alpha-1-antitrypsin deficiency are presented. Cord blood samples with an alpha-1-antitrypsin concentration below 1.628 mg/ml, as measured by an enzyme-linked immunosorbent assay method, were phenotyped by isoelectric focusing in polyacrylamide gels.

Liver disease in children with pizz ฮฑ1-a
โœ Fayez K. Ghishan; Harry L. Greene ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 446 KB

We present our experience with 18 pediatric patients with a,-antitrypsin deficiency of the PiZZ phenotype. Fifteen patients (83%) presented with neonatal cholestatic jaundice at a mean age of 2 f 0.6 months (2S.D.). The ma1e:female ratio was 15:3, indicating a male predominance. All metabolic, infec

Alpha-1-antitrypsin deficiency: A new pa
โœ David A. Rudnick; David H. Perlmutter ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 867 KB

Liver disease in alpha-1-antitrypsin (alpha1AT) deficiency is caused by a gain-of-toxic function mechanism engendered by the accumulation of a mutant glycoprotein in the endoplasmic reticulum (ER). The extraordinary degree of variation in phenotypical expression of this liver disease is believed to

Molecular pathogenesis of alpha-1-antitr
โœ David H. Perlmutter; Jeffrey L. Brodsky; William F. Balistreri; Bruce C. Trapnel ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 321 KB

In recent years, we have witnessed several important paradigm shifts in understanding the molecular basis of liver disease in alpha-1-antitrypsin (AT) deficiency. These shifts have become possible as a result of a number of advances in research on the cell biology of aggregation-prone mutant protein